Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Adaptor-mediated Lon proteolysis restricts Bacillus subtilis hyperflagellation.

Mukherjee S, Bree AC, Liu J, Patrick JE, Chien P, Kearns DB.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):250-5. doi: 10.1073/pnas.1417419112. Epub 2014 Dec 23.

2.

Swarming motility and the control of master regulators of flagellar biosynthesis.

Patrick JE, Kearns DB.

Mol Microbiol. 2012 Jan;83(1):14-23. doi: 10.1111/j.1365-2958.2011.07917.x. Epub 2011 Nov 22. Review.

3.

Community-associated methicillin-resistant Staphylococcus aureus infections at an Army training installation.

Morrison-Rodriguez SM, Pacha LA, Patrick JE, Jordan NN.

Epidemiol Infect. 2010 May;138(5):721-9. doi: 10.1017/S0950268810000142. Epub 2010 Jan 25.

PMID:
20096150
4.

Laboratory strains of Bacillus subtilis do not exhibit swarming motility.

Patrick JE, Kearns DB.

J Bacteriol. 2009 Nov;191(22):7129-33. doi: 10.1128/JB.00905-09. Epub 2009 Sep 11.

5.

Growing Bacillus subtilis tendrils sense and avoid each other.

James BL, Kret J, Patrick JE, Kearns DB, Fall R.

FEMS Microbiol Lett. 2009 Sep;298(1):12-9. doi: 10.1111/j.1574-6968.2009.01665.x.

6.

MinJ (YvjD) is a topological determinant of cell division in Bacillus subtilis.

Patrick JE, Kearns DB.

Mol Microbiol. 2008 Dec;70(5):1166-79. doi: 10.1111/j.1365-2958.2008.06469.x. Epub 2008 Oct 2.

7.

Disposition of desloratadine in healthy volunteers.

Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE.

Xenobiotica. 2007 Jul;37(7):770-87.

PMID:
17620222
8.

Disposition of loratadine in healthy volunteers.

Ramanathan R, Reyderman L, Kulmatycki K, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE.

Xenobiotica. 2007 Jul;37(7):753-69.

PMID:
17620221
9.

Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 351125, a CCR5 antagonist.

Ghosal A, Chowdhury SK, Gupta S, Yuan Y, Iannucci R, Zhang H, Zbaida S, Patrick JE, Alton KB.

Xenobiotica. 2005 May;35(5):405-17.

PMID:
16012074
10.

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.

Ghosal A, Yuan Y, Hapangama N, Su AD, Alvarez N, Chowdhury SK, Alton KB, Patrick JE, Zbaida S.

Biopharm Drug Dispos. 2004 Sep;25(6):243-52.

PMID:
15334623
11.

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).

Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S.

Drug Metab Dispos. 2004 Mar;32(3):314-20.

PMID:
14977865
12.

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil).

Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S.

Drug Metab Dispos. 2004 Feb;32(2):267-71.

PMID:
14744950
13.

Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes.

Ghosal A, Hapangama N, Yuan Y, Lu X, Horne D, Patrick JE, Zbaida S.

Biopharm Drug Dispos. 2003 Dec;24(9):375-84.

PMID:
14689466
14.

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB.

Br J Clin Pharmacol. 2002 Sep;54(3):309-19.

15.

High-performance liquid chromatographic method for the quantification of unbound evernimicin in human plasma ultrafiltrate.

Zhong R, Hernandez A, Alton KB, Kishnani NS, Patrick JE.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 25;772(1):191-5.

PMID:
12016032
16.

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.

Patrick JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, Statkevich P, Iannucci R, Chowdhury S, Affrime M, Cayen MN.

Drug Metab Dispos. 2002 Apr;30(4):430-7.

PMID:
11901097
17.

Fragmentation of N-oxides (deoxygenation) in atmospheric pressure ionization: investigation of the activation process.

Tong W, Chowdhury SK, Chen JC, Zhong R, Alton KB, Patrick JE.

Rapid Commun Mass Spectrom. 2001;15(22):2085-90.

PMID:
11746872
18.

In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophages.

Zbaida S, Brieland J, Krieter P, Loebenberg D, Krishna G, Horne D, Lu X, Yuan Y, Hare R, Cayen MN, Patrick JE.

Antimicrob Agents Chemother. 2001 Mar;45(3):959-61.

19.

In vitro metabolism of 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)- one, a topical antipsoriatic agent. Use of precision-cut rat, dog, monkey and human liver slices, and chemical synthesis of metabolites.

Zbaida S, Du Y, Shannon D, Laudicina D, Thonoor CM, Ng K, Blumenkrantz N, Patrick JE, Cayen MN, Friary R, Seidl V, Chan TM, Pramanik B, Spangler M, McPhail AT.

Biopharm Drug Dispos. 1998 Jul;19(5):315-32.

PMID:
9673784
20.

Disposition of 14C-eptifibatide after intravenous administration to healthy men.

Alton KB, Kosoglou T, Baker S, Affrime MB, Cayen MN, Patrick JE.

Clin Ther. 1998 Mar-Apr;20(2):307-23.

PMID:
9589822
21.

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.

Kosoglou T, Patrick JE, Cohen A, Radwanski E, Christopher D, Affrime MB.

Clin Ther. 1995 Mar-Apr;17(2):241-51.

PMID:
7614524
22.

Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet.

Kosoglou T, Kazierad DJ, Schentag JJ, Patrick JE, Heimark L, Radwanski E, Christopher D, Flannery BE, Affrime MB.

J Clin Pharmacol. 1995 Feb;35(2):151-8.

PMID:
7751425
23.

Cerebral oxidative metabolism in fetal sheep with prolonged and graded hypoxemia.

Richardson BS, Carmichael L, Homan J, Patrick JE.

J Dev Physiol. 1993 Feb;19(2):77-83.

PMID:
8409278
25.

Electrocortical activity, electroocular activity, and breathing movements in fetal sheep with prolonged and graded hypoxemia.

Richardson BS, Carmichael L, Homan J, Patrick JE.

Am J Obstet Gynecol. 1992 Aug;167(2):553-8.

PMID:
1497069
26.

Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Wagner JG, Ganes DA, Midha KK, Gonzalez-Younes I, Sackellares JC, Olson LD, Affrime MB, Patrick JE.

J Pharmacokinet Biopharm. 1991 Aug;19(4):413-55.

27.

Blood flow and oxygen delivery to fetal organs and tissues during sustained hypoxemia.

Rurak DW, Richardson BS, Patrick JE, Carmichael L, Homan J.

Am J Physiol. 1990 May;258(5 Pt 2):R1116-22.

PMID:
2337194
28.

Oxygen consumption in the fetal lamb during sustained hypoxemia with progressive acidemia.

Rurak DW, Richardson BS, Patrick JE, Carmichael L, Homan J.

Am J Physiol. 1990 May;258(5 Pt 2):R1108-15.

PMID:
2337193
29.

Pharmacokinetics and pharmacodynamics of dilevalol.

Tenero DM, Bottorff MB, Given BD, Kramer WG, Affrime MB, Patrick JE, Lalonde RL.

Clin Pharmacol Ther. 1989 Dec;46(6):648-56.

PMID:
2598569
30.

Pharmacokinetics of dilevalol in normotensive and hypertensive volunteers.

Kramer WG, Perentesis G, Affrime MB, Patrick JE.

Am J Cardiol. 1989 Jun 5;63(19):7I-11I.

PMID:
2729127
31.

Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.

Given BD, Perentesis G, Christopher JD, Herron J, Patrick JE, Kramer WG, Affrime MB.

Am J Cardiol. 1989 Jun 5;63(19):12I-16I.

PMID:
2729123
32.

Influence of food on the absorption of albuterol Repetabs.

Bolinger AM, Young KY, Gambertoglio JG, Newth CJ, Zureikat G, Powell M, Leung P, Affrime MB, Symchowicz S, Patrick JE.

J Allergy Clin Immunol. 1989 Jan;83(1):123-6.

PMID:
2913132
33.

Cerebral oxidative metabolism during sustained hypoxaemia in fetal sheep.

Richardson BS, Rurak D, Patrick JE, Homan J, Carmichael L.

J Dev Physiol. 1989 Jan;11(1):37-43.

PMID:
2794387
34.

Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers.

Kramer WG, Nagabhushan N, Affrime MB, Perentesis GP, Symchowicz S, Patrick JE.

J Clin Pharmacol. 1988 Jul;28(7):644-8.

PMID:
3216030
35.

Secretion of dilevalol in breast milk.

Radwanski E, Nagabhushan N, Affrime MB, Perentesis G, Symchowicz S, Patrick JE.

J Clin Pharmacol. 1988 May;28(5):448-53.

PMID:
2899094
36.
37.

Perinatal pulmonary hyperplasia due to laryngeal atresia.

Silver MM, Thurston WA, Patrick JE.

Hum Pathol. 1988 Jan;19(1):110-3.

PMID:
3335385
38.

Comparative steady state bioavailability of conventional and controlled-release formulations of albuterol.

Powell ML, Weisberger M, Dowdy Y, Gural R, Symchowicz S, Patrick JE.

Biopharm Drug Dispos. 1987 Sep-Oct;8(5):461-8.

PMID:
3663882
39.

High-performance liquid chromatographic assay for azatadine in human urine.

Alton KB, Petruzzi RF, Patrick JE.

J Chromatogr. 1987 Jan 9;385:249-59.

PMID:
2881936
40.

Plasma adrenocorticotropic hormone and cortisol and adrenal blood flow during sustained hypoxemia in fetal sheep.

Challis JR, Richardson BS, Rurak D, Wlodek ME, Patrick JE.

Am J Obstet Gynecol. 1986 Dec;155(6):1332-6.

PMID:
3024490
41.

Multiple-dose albuterol kinetics.

Powell ML, Chung M, Weisberger M, Gural R, Radwanski E, Symchowicz S, Patrick JE.

J Clin Pharmacol. 1986 Nov-Dec;26(8):643-6.

PMID:
3793958
42.

Rising multiple-dose pharmacokinetics of labetalol in hypertensive patients.

Chung M, Leitz FH, Maier G, Patrick JE, Gural RP, Symchowicz S.

J Clin Pharmacol. 1986 Apr;26(4):248-52.

PMID:
3700682
43.

High-performance liquid chromatographic assay for hydrochlorothiazide in human urine.

Alton KB, Desrivieres D, Patrick JE.

J Chromatogr. 1986 Jan 10;374(1):103-10.

PMID:
3949917
44.

Cerebral metabolism in fetal lamb after maternal infusion of ethanol.

Richardson BS, Patrick JE, Bousquet J, Homan J, Brien JF.

Am J Physiol. 1985 Nov;249(5 Pt 2):R505-9.

PMID:
4061674
45.

Cerebral oxidative metabolism in the fetal lamb: relationship to electrocortical state.

Richardson BS, Patrick JE, Abduljabbar H.

Am J Obstet Gynecol. 1985 Oct 15;153(4):426-31.

PMID:
4050916
46.

Comparative bioavailability and pharmacokinetics of three formulations of albuterol.

Powell ML, Weisberger M, Gural R, Chung M, Patrick JE, Radwanski E, Symchowicz SS.

J Pharm Sci. 1985 Feb;74(2):217-9.

PMID:
3989697
47.
48.

Biotransformation of norgestimate in women.

Alton KB, Hetyei NS, Shaw C, Patrick JE.

Contraception. 1984 Jan;29(1):19-29.

PMID:
6734203
49.

Quantitative analysis of albuterol in human plasma by combined gas chromatography chemical ionization mass spectrometry.

Weisberger M, Patrick JE, Powell ML.

Biomed Mass Spectrom. 1983 Oct;10(10):556-8.

PMID:
6652230
50.

Ultrasonic measurement of rate and depth of human fetal breathing: effect of glucose.

Adamson SL, Bocking A, Cousin AJ, Rapoport I, Patrick JE.

Am J Obstet Gynecol. 1983 Oct 1;147(3):288-95.

PMID:
6624794

Supplemental Content

Loading ...
Support Center